| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1043306332 |
| P356 | DOI | 10.1038/SJ.ONC.1202349 |
| P698 | PubMed publication ID | 9989814 |
| P5875 | ResearchGate publication ID | 13299279 |
| P2093 | author name string | Bryant D | |
| Behrens C | |||
| Gazdar AF | |||
| Milchgrub S | |||
| Wistuba II | |||
| Minna JD | |||
| Hung J | |||
| P2860 | cites work | The FHIT gene 3p14.2 is abnormal in lung cancer. | Q53455201 |
| Multiple-mutation theory of carcinogenesis. | Q53615521 | ||
| Development of carcinoma of the lung as reflected in exfoliated cells. | Q53719094 | ||
| Simplified hot start PCR | Q59061373 | ||
| Detection of loss of heterozygosity at the human TP53 locus using a dinucleotide repeat polymorphism | Q67544701 | ||
| Sputum cytopathology: use and potential in monitoring the workplace environment by screening for biological effects of exposure | Q69595094 | ||
| Microsatellite instability in primary and metastatic lung carcinomas | Q71010040 | ||
| Genomic instability, mutators, and the development of cancer: is there a role for p53? | Q71807913 | ||
| Clonal genetic alterations in the lungs of current and former smokers | Q73443322 | ||
| The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers | Q24321912 | ||
| Widely dispersed p53 mutation in respiratory epithelium. A novel mechanism for field carcinogenesis | Q24561466 | ||
| 'Touchdown' PCR to circumvent spurious priming during gene amplification | Q24630793 | ||
| Complete genomic sequence of the human retinoblastoma susceptibility gene | Q28236997 | ||
| The clonal evolution of tumor cell populations | Q28271546 | ||
| Allelotype of colorectal carcinomas | Q34461209 | ||
| Microsatellite alterations as clonal markers for the detection of human cancer | Q35819311 | ||
| Frequency of allele loss of DCC, p53, RBI, WT1, NF1, NM23 and APC/MCC in colorectal cancer assayed by fluorescent multiplex polymerase chain reaction | Q36080181 | ||
| Molecular damage in the bronchial epithelium of current and former smokers | Q37541079 | ||
| Comparison of molecular changes in lung cancers in HIV-positive and HIV-indeterminate subjects | Q38471959 | ||
| Allele-specific loss in chromosome 9p loci in preneoplastic lesions accompanying non-small-cell lung cancers | Q38480210 | ||
| Allele-specific chromosome 3p deletions occur at an early stage in the pathogenesis of lung carcinoma | Q38481338 | ||
| Loss of heterozygosity in normal tissue adjacent to breast carcinomas. | Q45975916 | ||
| At least one in seven cases of cancer is caused by smoking. Global estimates for 1985. | Q50600385 | ||
| Cancer statistics, 1997. | Q50980276 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 643-650 | |
| P577 | publication date | 1999-01-01 | |
| P1433 | published in | Oncogene | Q1568657 |
| P1476 | title | Sequential molecular abnormalities are involved in the multistage development of squamous cell lung carcinoma | |
| P478 | volume | 18 |
| Q35042319 | A novel differential diagnostic model for multiple primary lung cancer: Differentially-expressed gene analysis of multiple primary lung cancer and intrapulmonary metastasis |
| Q33877437 | Advances in sputum analysis for screening and early detection of lung cancer |
| Q35586846 | Allelic imbalance at chromosome 11 in head and neck squamous cell carcinoma in an Indian patient population |
| Q37355446 | Allelic losses on chromosome 3p are accumulated in relation to morphological changes of lung adenocarcinoma |
| Q53369650 | Analytical and statistical methods to evaluate microsatellite allelic imbalance in small amounts of DNA. |
| Q40765128 | Aneuploidy of chromosome 7 can be detected in invasive lung cancer and associated premalignant lesions of the lung by fluorescence in situ hybridisation |
| Q31909986 | Association of allelic loss at the FHIT locus and p53 alterations with tumour kinetics and chromosomal instability in non-small cell lung carcinomas (NSCLCs). |
| Q34031219 | C4.4A as a biomarker in pulmonary adenocarcinoma and squamous cell carcinoma |
| Q36195562 | CT Characteristic of Early Local Recurrence After Resection of the Squamous Cell Carcinoma: Comparison With CT Characteristics of Stump Deformity or Granulation Tissue at Stump Site |
| Q39926329 | Cell migration leads to spatially distinct but clonally related airway cancer precursors. |
| Q37175654 | Characterizing the molecular spatial and temporal field of injury in early-stage smoker non-small cell lung cancer patients after definitive surgery by expression profiling |
| Q36414871 | Chromosomal aneusomy in bronchial high-grade lesions is associated with invasive lung cancer |
| Q28360494 | Chromosome 3p allele loss in early invasive breast cancer: detailed mapping and association with clinicopathological features. |
| Q53494880 | Chromosome 9 instability and alterations of p16 gene in squamous cell carcinoma of the lung and in adjacent normal bronchi: FISH and immunohistochemical study. |
| Q57306273 | Circulating cell-free DNA: a potential biomarker in lung cancer |
| Q39647590 | Clld7, A Candidate Tumor Suppressor on Chromosome 13q14, Regulates Pathways of DNA Damage/Repair and Apoptosis |
| Q80529481 | Clonal divergence in lung cancer development is associated with allelic loss on chromosome 4 |
| Q34810714 | Clonality of multifocal urothelial carcinomas: 10 years of molecular genetic studies |
| Q58572462 | Critical tumor-suppressor gene regions on chromosome 3P in major human epithelial malignancies: Allelotyping and quantitative real-time PCR |
| Q34984208 | Cytogenetics and molecular genetics of lung cancer |
| Q83174926 | Deletion mapping of chromosome 13q in head and neck squamous cell carcinoma in Indian patients: correlation with prognosis of the tumour |
| Q74486037 | Deletion of tumor suppressor genes in Chinese non-small cell lung cancer |
| Q53275538 | Detecting the Presence and Progression of Premalignant Lung Lesions via Airway Gene Expression. |
| Q31120595 | Differential analysis of two-dimension gel electrophoresis profiles from the normal-metaplasia-dysplasia-carcinoma tissue of human bronchial epithelium |
| Q79156005 | Differential deletions in 3p are associated with the development of head and neck squamous cell carcinoma in Indian patients |
| Q33919221 | Differential deletions of chromosome 3p are associated with the development of uterine cervical carcinoma in Indian patients |
| Q42485639 | EGFR/erB-1, HER2/erB-2, CK7, LP34, Ki67 and P53 expression in preneoplastic lesions of bronchial epithelium: an immunohistochemical and genetic study |
| Q36014004 | Epidermal growth factor receptor abnormalities in the pathogenesis and progression of lung adenocarcinomas |
| Q24291194 | Epigenetic inactivation of RASSF1A in lung and breast cancers and malignant phenotype suppression |
| Q30884723 | Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3. |
| Q42810857 | Expression and alteration of ras and p53 proteins in patients with lung carcinoma accompanied by idiopathic pulmonary fibrosis |
| Q42492165 | Expression of C4.4A in precursor lesions of pulmonary adenocarcinoma and squamous cell carcinoma |
| Q33791329 | Expression of c-kit and p53 in non-small cell lung cancers |
| Q53394313 | Expression of early lung cancer detection marker: hnRNP-A2/B1 and its relation to microsatellite alteration in non-small cell lung cancer. |
| Q24625463 | Expression of several genes in the human chromosome 3p21.3 homozygous deletion region by an adenovirus vector results in tumor suppressor activities in vitro and in vivo |
| Q34272221 | Field cancerization in non-small cell lung cancer: implications in disease pathogenesis |
| Q30721136 | Fluorescence versus white-light bronchoscopy for detection of preneoplastic lesions: a randomized study |
| Q34710709 | Focus on lung cancer |
| Q35747975 | Fragile histidine triad gene abnormalities in the pathogenesis of gallbladder carcinoma |
| Q74523064 | Frequent 3p allele loss and epigenetic inactivation of the RASSF1A tumour suppressor gene from region 3p21.3 in head and neck squamous cell carcinoma |
| Q24621422 | Functional properties of a new voltage-dependent calcium channel alpha(2)delta auxiliary subunit gene (CACNA2D2) |
| Q74000663 | Genetic analysis of Raf1, Mdm2, c-Myc, Cdc25a and Cdc25b proto-oncogenes in 2',3'-dideoxycytidine- and 1,3-butadiene-induced lymphomas in B6C3F1 mice |
| Q73311455 | Genetic heterogeneity in lung and colorectal carcinoma as revealed by microsatellite analysis in plasma or tumor tissue DNA |
| Q48077597 | Genome-wide copy number changes and CD133 expression characterized distinct subset of colon polyps: differentiation between incidental polyps and cancer-associated polyps |
| Q33569956 | Genomic Landscape Established by Allelic Imbalance in the Cancerization Field of a Normal Appearing Airway |
| Q36043875 | Genomic evidence of pre-invasive clonal expansion, dispersal and progression in bronchial dysplasia |
| Q49560201 | Genomic variations in the counterpart normal controls of lung squamous cell carcinomas |
| Q33777454 | Genomics of squamous cell lung cancer |
| Q36645990 | High resolution chromosome 3p, 8p, 9q and 22q allelotyping analysis in the pathogenesis of gallbladder carcinoma |
| Q42489421 | Histological types and significance of bronchial epithelial dysplasia |
| Q53310756 | IV international conference on prevention and early detection of lung cancer, Reykjavik, Iceland, August 9-12, 2001. |
| Q24291619 | Identification of AXUD1, a novel human gene induced by AXIN1 and its reduced expression in human carcinomas of the lung, liver, colon and kidney |
| Q34936005 | Innovative molecular and imaging approaches for the detection of lung cancer and its precursor lesions |
| Q36980449 | Issues in the design and interpretation of chronic toxicity and carcinogenicity studies in rodents: approaches to dose selection. |
| Q90701810 | Lingular segmentectomy and left lower lobectomy via unique bronchial dissection |
| Q34680492 | Loss of 4q21.23-22.1 is a prognostic marker for disease free and overall survival in non-small cell lung cancer. |
| Q24299088 | Loss of PL6 protein expression in renal clear cell carcinomas and other VHL-deficient tumours |
| Q57240046 | Loss of chromosome arms 3p and 9p and inactivation ofP16INK4a in normal epithelium of patients with primary lung cancer |
| Q80148666 | Loss of heterozygosity and human telomerase reverse transcriptase (hTERT) expression in bronchial mucosa of heavy smokers |
| Q74129109 | Loss of heterozygosity in tumour-adjacent normal tissue of breast and bladder cancer |
| Q36622470 | Loss of heterozygosity is related to p53 mutations and smoking in lung cancer |
| Q38679289 | Lung Cancer Genomics in the Era of Accelerated Targeted Drug Development. |
| Q93062897 | Lung Cancer Staging and Associated Genetic and Epigenetic Events |
| Q33972805 | Lung cancer * 9: Molecular biology of lung cancer: clinical implications |
| Q35075591 | Lung cancer . 3: Fluorescence bronchoscopy: clinical dilemmas and research opportunities |
| Q26995495 | Lung cancer chemoprevention: current status and future prospects |
| Q35179464 | Lung cancer chemoprevention: moving from concept to a reality |
| Q34569420 | Lung cancer evolution to preinvasive management |
| Q24552865 | MCG10, a novel p53 target gene that encodes a KH domain RNA-binding protein, is capable of inducing apoptosis and cell cycle arrest in G(2)-M |
| Q44588658 | Mapping of the candidate tumor suppressor genes' loci on human chromosome 3 in head and neck squamous cell carcinoma of an Indian patient population |
| Q43583310 | Methylation associated inactivation of RASSF1A from region 3p21.3 in lung, breast and ovarian tumours. |
| Q34835468 | Methylation of the RASSF1A gene in human cancers |
| Q35836697 | Microsatellite analysis of pleural supernatants could increase sensitivity of pleural fluid cytology |
| Q79319023 | Microscopic analysis of chromium accumulation in the bronchi and lung of chromate workers |
| Q33891465 | Molecular and genetic aspects of lung cancer |
| Q34569440 | Molecular biology of lung cancer: clinical implications. |
| Q37511952 | Molecular changes in the bronchial epithelium of patients with small cell lung cancer |
| Q43955974 | Molecular follow-up of preneoplastic lesions in bronchial epithelium of former Chernobyl clean-up workers |
| Q33722441 | Molecular genetic characteristics of lung cancer--useful as real' tumor markers? |
| Q33793308 | Molecular pathogenesis of lung cancer |
| Q36155104 | Molecular pathology of non-small-cell lung cancer |
| Q36691733 | Molecular profiling of lung carcinoma: identifying clinically useful tumor markers for diagnosis and prognosis |
| Q64097509 | Molecular subtyping reveals immune alterations associated with progression of bronchial premalignant lesions |
| Q35542147 | Multi-stage chemical carcinogenesis in mouse skin: fundamentals and applications |
| Q33879000 | Multiple clonal abnormalities in the bronchial epithelium of patients with lung cancer |
| Q36157758 | Natural history of bronchial preinvasive lesions |
| Q64282336 | Neoplastic Pathogenesis Associated with Cigarette Carcinogens |
| Q38089079 | New biomarkers for lung cancer |
| Q35156742 | Novel candidate key drivers in the integrative network of genes, microRNAs, methylations, and copy number variations in squamous cell lung carcinoma. |
| Q53628984 | Nuclear morphometry as a biomarker for bronchial intraepithelial neoplasia: correlation with genetic damage and cancer development. |
| Q40671231 | Pathogenetic and biologic significance of TP14ARF alterations in nonsmall cell lung carcinoma |
| Q36446587 | Persistence of Bronchial Dysplasia Is Associated with Development of Invasive Squamous Cell Carcinoma |
| Q28482937 | Phase I clinical trial of systemically administered TUSC2(FUS1)-nanoparticles mediating functional gene transfer in humans |
| Q24807204 | Preneoplastic lesions of the lung |
| Q39541029 | Promoter hypermethylation of the CFTR gene and clinical/pathological features associated with non-small cell lung cancer. |
| Q73497850 | Prospects for lung-cancer screening |
| Q28395348 | Pulmonary adenocarcinoma: a renewed entity in 2011 |
| Q34220494 | Pulmonary preinvasive neoplasia |
| Q38009322 | RASSF Signalling and DNA Damage: Monitoring the Integrity of the Genome? |
| Q33955907 | Retrovirus-induced ovine pulmonary adenocarcinoma, an animal model for lung cancer |
| Q44798575 | SOX2 Drives Bronchial Dysplasia in a Novel Organotypic Model of Early Human Squamous Lung Cancer. |
| Q36202378 | SOX2 and PI3K Cooperate to Induce and Stabilize a Squamous-Committed Stem Cell Injury State during Lung Squamous Cell Carcinoma Pathogenesis. |
| Q33842487 | Smoking and lung cancer: the role of inflammation |
| Q34963435 | Smoking molecular damage in bronchial epithelium |
| Q81817041 | Somatic genetic changes accompanying lung tumor development |
| Q50977348 | Spectra of antinuclear antibodies in patients with squamous cell carcinoma of the lung and of the head and neck. |
| Q36030691 | Squamous Metaplasia Is Increased in the Bronchial Epithelium of Smokers with Chronic Obstructive Pulmonary Disease |
| Q38048579 | Squamous-cell carcinomas of the lung: emerging biology, controversies, and the promise of targeted therapy |
| Q37571960 | Stem cells and lung cancer: future therapeutic targets? |
| Q40592131 | Suprabasal p53 immunostaining in premalignant endobronchial lesions in combination with histology is associated with bronchial cancer. |
| Q24617128 | Surfactant protein DNA methylation: a new entrant in the field of lung cancer diagnostics? (Review) |
| Q64975920 | TRIM58/cg26157385 methylation is associated with eight prognostic genes in lung squamous cell carcinoma. |
| Q24816722 | Teen smoking, field cancerization, and a "critical period" hypothesis for lung cancer susceptibility |
| Q43655920 | The CpG island of the novel tumor suppressor gene RASSF1A is intensely methylated in primary small cell lung carcinomas |
| Q31121564 | The Ras-association domain family (RASSF) members and their role in human tumourigenesis |
| Q35078733 | The TP53 gene, tobacco exposure, and lung cancer |
| Q34510214 | The association between atypical adenomatous hyperplasia and primary lung cancer |
| Q38296670 | The hypoxic tumor microenvironment: driving the tumorigenesis of non-small-cell lung cancer |
| Q24802445 | The molecular basis of lung cancer: molecular abnormalities and therapeutic implications |
| Q27010437 | The pivotal role of pathology in the management of lung cancer |
| Q35200467 | The use of quantitative proteomics towards biomarker discovery in lung squamous cell carcinoma |
| Q53394311 | Topographical analysis of p53 expression and DNA ploidy in early bronchial squamous cell carcinoma and preneoplastic lesions. |
| Q79347789 | Topographical distribution of allelic loss in individual lung adenocarcinomas with lymph node metastases |
| Q37696458 | Transcriptomic architecture of the adjacent airway field cancerization in non-small cell lung cancer |
| Q34997208 | Transformation of rodent fibroblasts by the jaagsiekte sheep retrovirus envelope is receptor independent and does not require the surface domain. |
| Q36245778 | Whole Transcriptome Analysis of Pre-invasive and Invasive Early Squamous Lung Carcinoma in Archival Laser Microdissected Samples |
Search more.